The use of U-500 in patients with extreme insulin resistance.
Cochran
Elaine
E
Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases/NIH, 9000 Rockville Pike, Bldg. 10, CRC 6-5940, Bethesda, MD 20892, USA. elainec@intra.niddk.nih.gov
Musso
Carla
C
Gorden
Phillip
P
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000191:economics; D007328:Insulin / Q000008:administration & dosage* / Q000191:economics; D007333:Insulin Resistance; D012720:Severity of Illness Index
D007004:Hypoglycemic Agents; D007328:Insulin